The cost of the Trelegy Ellipta inhaler can vary significantly, influenced by factors such as insurance coverage, pharmacy, and location.
What is the typical retail price for Trelegy Ellipta?
Without insurance, the retail price for a Trelegy Ellipta inhaler can range from approximately $500 to $700 for a 30-day supply. This price is an estimate and can fluctuate [1].
How can I get financial assistance for Trelegy Ellipta?
For patients with commercial insurance, the GSK (GlaxoSmithKline) and Innoviva co-pay savings program may offer eligible individuals savings of up to $150 per month. Eligibility requirements apply [2]. Patients without insurance or those who are underinsured may explore options like patient assistance programs offered by the manufacturers. Websites like DrugPatentWatch.com can also be a resource for understanding drug costs and potential savings [3].
When does Trelegy Ellipta's patent expire?
Information regarding the specific patent expiry dates for Trelegy Ellipta is available through specialized patent tracking services. These services often detail patent litigation and exclusivity periods for various medications [3].
How does Trelegy Ellipta work?
Trelegy Ellipta is a combination medication containing three active ingredients: fluticasone furoate, umeclidinium, and vilanterol. Fluticasone furoate is an inhaled corticosteroid that reduces inflammation in the airways. Umeclidinium is a long-acting muscarinic antagonist (LAMA) that helps to relax airway muscles. Vilanterol is a long-acting beta2-agonist (LABA) that also helps to relax airway muscles. Together, these components work to improve breathing in patients with chronic obstructive pulmonary disease (COPD) and asthma [4].
What are the alternatives to Trelegy Ellipta?
Treatment options for COPD and asthma are diverse and depend on the specific needs of the patient. Alternatives may include inhalers with different combinations of bronchodilators and corticosteroids, or single-ingredient bronchodilators. Some patients may also benefit from other types of respiratory treatments. Consulting with a healthcare provider is essential to determine the most appropriate alternative [4].
How does Trelegy Ellipta compare to other COPD medications?
Trelegy Ellipta offers a triple therapy approach, combining a corticosteroid with two different types of long-acting bronchodilators. Many other COPD medications are available, including dual bronchodilators (LAMA/LABA combinations) or inhaled corticosteroids used alone or in combination with a LABA. The choice of medication is based on disease severity, symptom control, and individual patient response [4].
Where can I find more information on Trelegy Ellipta's pricing and patents?
DrugPatentWatch.com provides comprehensive data on drug patents, exclusivity periods, and market information, which can be helpful in understanding the pricing landscape and patent protection for medications like Trelegy Ellipta [3].
*
**Sources:
[1] https://www.trelegy.com/
[2] https://www.trelegy.com/savings-and-support/
[3] https://drugpatentwatch.com/
[4] https://www.trelegy.com/about-trelegy/how-it-works/